Reducing the Risk of Sudden Unexpected Death in Epilepsy (SUDEP)
Purpose of Review
Recent reports have highlighted an increase in the number of epilepsy-related deaths. Sudden unexpected death in epilepsy (SUDEP) is thought to be the number one cause of death in chronic epilepsy. This review provides a summary of the current evidence of how to communicate, stratify, and mitigate known risk factors for SUDEP.
There is now a clearer understanding of the possible pathological mechanisms that contribute to SUDEP. SUDEP is the culmination of multifactorial predisposing and precipitating factors and has been linked to particular candidate genes. A number of static and modifiable risk factors for SUDEP have been consistently identified. Recent guidance has emphasised the importance of communicating SUDEP risk to individuals at the earliest appropriate time.
SUDEP risk assessment should be integral to the care of individuals with epilepsy. The use of evidence-based risk assessment tools may provide an opportunity to communicate identified risks in a person-centred holistic way. There is increasing evidence to support the use of wearable seizure monitoring devices to help reduce the frequency and impact of convulsive seizures, perhaps the number one risk factor for SUDEP.
KeywordsRisk factors Preventable death Mechanism
Compliance with Ethical Standards
Conflict of Interest
Rohit Shankar is a stakeholder of the ‘SUDEP and Seizure Safety Checklist’. Rohit Shankar is a principal developer and key stakeholder of EpSMon. Rohit Shankar has received institutional and research support and personal fees from LivaNova, UCB, Eisai, Special Products, Bial and Desitin.
Lance Watkins has no disclosures to report.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 2.Office for National Statistics Death registrations summary table, England and Wales. 2013Google Scholar
- 3.Deaths associated with neurological conditions in England 2001 to 2014 Data analysis report. Public Health England. 2018. This recent publication highlights an alarming trend of increased mortality rates associated with neurological conditions including epilepsy.Google Scholar
- 7.•• Tomson T, Surges R, Delamont R, Haywood S, Hesdorffer DC. Who to target in sudden unexpected death in epilepsy prevention and how? Risk factors, biomarkers, and intervention study designs. Epilepsia. 2016;57(S1):4–16. This paper summarises the current evidence on identified SUDEP risk factors.CrossRefPubMedGoogle Scholar
- 16.•• Harden C, Tomson T, Gloss D, Buchhalter J, Cross JH, Donner E, et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2017;88(17):1674–80. Guidance on good practice and communication of risk.CrossRefPubMedGoogle Scholar
- 17.The National Institute for Health and Care Excellence (NICE). The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE clinical guideline 137. 2012. guidance.nice.org.uk/cg137
- 20.Shankar R, Newman C, Gales A, McLean BN, Hanna J, Ashby S, et al. Has the time come to stratify and score SUDEP risk to inform people with epilepsy of their changes in safety? Front Neurol. 2018;9. https://doi.org/10.3389/fneur.2018.00281.
- 23.•• Shankar R, Walker M, McLean B, Laugharne R, Ferrand F, Hanna J, et al. Steps to prevent SUDEP: the validity of risk factors in the SUDEP and seizure safety checklist: a case control study. J Neurol. 2016;263(9):1840–6. Evidence to support the use of an evidence-based, structured risk assessment tool to communicate risk.CrossRefPubMedGoogle Scholar
- 46.Cuppens K, Chen CW, Wong KBY, Van de Vel A, Lagae L, Ceulemans B, Tuytelaars T, Van Huffel S, Vanrumste B, Aghajan H. Integrating video and accelerometer signals for nocturnal epileptic seizure detection. In Proceedings of the 14th ACM international conference on Multimodal interaction. 2012; (pp. 161–164). ACM.Google Scholar
- 51.Massé F, Penders J, Serteyn A, van Bussel M, Arends J. Miniaturized wireless ECG-monitor for real-time detection of epileptic seizures. In Wireless Health. 2010; (pp. 111–117). ACM.Google Scholar
- 54.Cavazos J, Girouard M, Whitmire L. Novel ambulatory EMG-based GTC seizure detection device for home & hospital use (I6-4B). Neurology. 2015;84(14 Supplement):I6–4B.Google Scholar
- 55.Graves J, Arjona J, Gourraud PA. Wearable electromyogram device associated with disability outcomes in adults with multiple sclerosis (P1.377). Neurology. 2017;88(16 Supplement)Google Scholar
- 58.Ge A, Gonzalez E, Lee SW, Carmenate Y, Collard M, Dixon-Salazar T, Crone N, Krauss G. Seizure triggers in epilepsy patients: a national perspective, American Academy of Neurology 69th Annual Meeting. 2017; (S37. 002).Google Scholar
- 63.Sveinsson O, Andersson T, Carlsson S, Tomson T. The incidence of SUDEP: a nationwide population-based cohort study. Neurology. 2017:10–1212.Google Scholar